المؤلفون: De Vecchis R; Preventive Cardiology and Rehabilitation Unit, DSB 29 'S. Gennaro dei Poveri Hospital', Naples., Paccone A; Department of Cardiology, University of Bari Aldo Moro, Bari., Di Maio M; Department of Cardiology, University of Campania 'Luigi Vanvitelli', Naples, Italy.

المصدر: Journal of cardiovascular medicine (Hagerstown, Md.) [J Cardiovasc Med (Hagerstown)] 2019 Dec; Vol. 20 (12), pp. 857-858.

نوع المنشور: Comparative Study; Letter; Multicenter Study

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101259752 Publication Model: Print Cited Medium: Internet ISSN: 1558-2035 (Electronic) Linking ISSN: 15582027 NLM ISO Abbreviation: J Cardiovasc Med (Hagerstown) Subsets: MEDLINE

مواضيع طبية MeSH: Aminobutyrates/*therapeutic use , Angiotensin II Type 1 Receptor Blockers/*therapeutic use , Angiotensin-Converting Enzyme Inhibitors/*therapeutic use , Heart Failure/*drug therapy , Protease Inhibitors/*therapeutic use , Stroke Volume/*drug effects , Tetrazoles/*therapeutic use , Ventricular Dysfunction, Left/*drug therapy , Ventricular Function, Left/*drug effects, Aged ; Aged, 80 and over ; Aminobutyrates/adverse effects ; Angiotensin II Type 1 Receptor Blockers/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Biphenyl Compounds ; Drug Combinations ; Female ; Heart Failure/diagnostic imaging ; Heart Failure/physiopathology ; Humans ; Italy ; Male ; Neprilysin/antagonists & inhibitors ; Protease Inhibitors/adverse effects ; Recovery of Function ; Retrospective Studies ; Tetrazoles/adverse effects ; Time Factors ; Treatment Outcome ; Valsartan ; Ventricular Dysfunction, Left/diagnostic imaging ; Ventricular Dysfunction, Left/physiopathology ; Ventricular Remodeling/drug effects

المؤلفون: Lagi F; Infectious Disease Unit, Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134, Firenze, (Italy)., Baldin G; Institute of Clinical Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, L. go Agostino Gemelli, 8 - 00168, Rome (Italy)., Colafigli M; Infectious Dermatology and Allergology Unit, IFO S. Gallicano Institute (IRCCS), via Elio Chianesi, 53 - 00144, Rome, (Italy)., Capetti A; Division of Infectious Diseases, Department of Infectious Diseases, Luigi Sacco University Hospital, via Giovanni Battista Grassi, 74, 20157, Milan, (Italy)., Madeddu G; Unit of Infectious Diseases, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Viale San Pietro, 10- 07100 Sassari, (Italy)., Kiros ST; Infectious Disease Unit, Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134, Firenze, (Italy)., Di Giambenedetto S; Institute of Clinical Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, L. go Agostino Gemelli, 8 - 00168, Rome (Italy)., Sterrantino G; Infectious Disease Unit, Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134, Firenze, (Italy). Electronic address: gaetana.sterrantino@unifi.it.

المصدر: International journal of antimicrobial agents [Int J Antimicrob Agents] 2019 Oct; Vol. 54 (4), pp. 487-490. Date of Electronic Publication: 2019 Jun 11.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE

مواضيع طبية MeSH: Antiretroviral Therapy, Highly Active/*methods , HIV Infections/*drug therapy , HIV Integrase Inhibitors/*therapeutic use , HIV Protease Inhibitors/*therapeutic use , Heterocyclic Compounds, 3-Ring/*therapeutic use , Reverse Transcriptase Inhibitors/*therapeutic use, Adult ; Antiretroviral Therapy, Highly Active/adverse effects ; CD4 Lymphocyte Count ; Female ; HIV Integrase Inhibitors/adverse effects ; HIV Protease Inhibitors/adverse effects ; Heterocyclic Compounds, 3-Ring/adverse effects ; Humans ; Italy ; Male ; Middle Aged ; Oxazines ; Piperazines ; Pyridones ; Reverse Transcriptase Inhibitors/adverse effects ; Sustained Virologic Response ; Treatment Outcome

المؤلفون: Daskapan A; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Tran QTD; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Cattaneo D; Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milano., Gervasoni C; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milano, Italy., Resnati C; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milano, Italy., Stienstra Y; Department of Internal Medicine-Infectious Diseases, University Medical Center Groningen, University of Groningen, Groningen., Bierman WFW; Department of Internal Medicine-Infectious Diseases, University Medical Center Groningen, University of Groningen, Groningen., Kosterink JGW; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Unit Pharmacotherapy, Epidemiology and Economy, Groningen Research Institute of Pharmacy, University of Groningen, Groningen., van der Werf TS; Department of Internal Medicine-Infectious Diseases, University Medical Center Groningen, University of Groningen, Groningen., Proost JH; Unit Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands., Alffenaar JC; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Touw DJ; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Unit Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands.

المصدر: Therapeutic drug monitoring [Ther Drug Monit] 2019 Feb; Vol. 41 (1), pp. 59-65.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print Cited Medium: Internet ISSN: 1536-3694 (Electronic) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE

مواضيع طبية MeSH: Darunavir/*pharmacokinetics , HIV Infections/*metabolism , HIV Protease Inhibitors/*pharmacokinetics, Adult ; Aged ; Bayes Theorem ; Darunavir/therapeutic use ; Female ; HIV Infections/drug therapy ; HIV Protease Inhibitors/therapeutic use ; HIV-1/drug effects ; Humans ; Italy ; Male ; Middle Aged ; Netherlands ; Outpatients ; Young Adult

المؤلفون: Lombardi F; Università Cattolica del Sacro Cuore, Dipartimento di Sicurezza e Bioetica Sezione Malattie Infettive, Rome, Italy., Giacomelli A; III Infectious Diseases Unit, ASST-FBF-Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy., Armenia D; UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy., Lai A; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy., Dusina A; Università Cattolica del Sacro Cuore, Dipartimento di Sicurezza e Bioetica Sezione Malattie Infettive, Rome, Italy., Bezenchek A; IPRO - InformaPRO S.r.l., Rome, Italy., Timelli L; IPRO - InformaPRO S.r.l., Rome, Italy., Saladini F; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Vichi F; Unit of Infectious Diseases, USL CENTRO Firenze, Italy., Corsi P; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy., Colao G; Laboratory of Virology, Careggi Hospital, Florence, Italy., Bruzzone B; Hygiene Unit, Ospedale Policlinico San Martino, Genoa, Italy., Gagliardini R; National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Callegaro A; Department of Laboratory Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy., Castagna A; Clinic of Infectious Diseases, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy., Santoro MM; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy. Electronic address: santormaria@gmail.com.

مؤلفون مشاركون: ARCA Study Group

المصدر: International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Feb; Vol. 57 (2), pp. 106252. Date of Electronic Publication: 2020 Nov 28.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents/*pharmacology , Anti-HIV Agents/*therapeutic use , HIV Infections/*drug therapy , HIV Infections/*virology , HIV-1/*drug effects, Adult ; Antiretroviral Therapy, Highly Active ; CD4 Lymphocyte Count ; Coinfection ; Drug Resistance, Multiple, Viral ; Female ; HIV Infections/complications ; HIV Infections/transmission ; HIV Integrase Inhibitors/pharmacology ; HIV Integrase Inhibitors/therapeutic use ; HIV Protease Inhibitors/pharmacology ; HIV Protease Inhibitors/therapeutic use ; Hepatitis B/complications ; Humans ; Italy ; Male ; Retrospective Studies ; Reverse Transcriptase Inhibitors/pharmacology ; Reverse Transcriptase Inhibitors/therapeutic use ; Risk Factors

المؤلفون: Lapadula G; Clinic of Infectious Diseases, AO 'San Gerardo de' Tintori,' Monza, Italy; †IRCCS Istituto di Ricerche Farmacologiche 'Mario Negri,' Milan, Italy; ‡University Division of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy; §Clinic of Infectious Diseases, Ospedali Riuniti, Bergamo, Italy; ‖Clinic of Infectious Diseases, 'Sacro Cuore' Catholic University, Rome, Italy; ¶Clinic of Infectious Diseases, Ospedale Sant'Anna, Ferrara, Italy; #Clinic of Infectious Diseases, Ospedale Policlinico, Bari, Italy; **Clinic of Infectious Diseases, Ospedale S.M. Annunziata, Florence, Italy; ††Clinic of Infectious Diseases, Istituti Ospitalieri, Cremona, Italy; ‡‡Clinic of Infectious Diseases, Spedali Civili, Brescia, Italy; and §§Department of Surgical and Medical Sciences, University 'Magna Graecia,' Catanzaro, Italy., Costarelli S, Chatenoud L, Castelli F, Astuti N, Di Giambenedetto S, Quiros-Roldan E, Sighinolfi L, Ladisa N, Di Pietro M, Zoncada A, Di Filippo E, Gori A, Nasta P, Torti C

مؤلفون مشاركون: Italian MASTER Cohort

المصدر: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2015 Jul 01; Vol. 69 (3), pp. 312-8.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 100892005 Publication Model: Print Cited Medium: Internet ISSN: 1944-7884 (Electronic) Linking ISSN: 15254135 NLM ISO Abbreviation: J Acquir Immune Defic Syndr Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents/*therapeutic use , HIV Infections/*complications , Hepatitis C/*complications , Liver/*enzymology , Protease Inhibitors/*therapeutic use , Ritonavir/*therapeutic use, Adult ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Cohort Studies ; Drug Therapy, Combination ; Female ; HIV Infections/drug therapy ; Hepatitis B/complications ; Humans ; Italy ; Liver/drug effects ; Male ; Middle Aged ; Protease Inhibitors/administration & dosage ; Protease Inhibitors/adverse effects ; Risk Factors ; Ritonavir/administration & dosage ; Ritonavir/adverse effects

المؤلفون: Armignacco O; Infectious Disease Unit, Belcolle Hospital, Viterbo, Italy., Andreoni M, Sagnelli E, Puoti M, Bruno R, Gaeta GB, Perno CF, Santantonio TA, Bonfanti P, Bonora S, Borderi M, Castagna A, d'Arminio Monforte A, De Luca A, Grossi P, Guaraldi G, Maggiolo F, Mussini C, Sagnelli C, Tavio M, Torti C, Uberti-Foppa C, Andreoni M, Angarano G, Antinori A, Armignacco O, Carosi G, Chirianni A, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Sagnelli E, Taliani G

المصدر: The new microbiologica [New Microbiol] 2014 Oct; Vol. 37 (4), pp. 423-38. Date of Electronic Publication: 2014 Oct 01.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Edizioni Internazionali srl Country of Publication: Italy NLM ID: 9516291 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1121-7138 (Print) Linking ISSN: 11217138 NLM ISO Abbreviation: New Microbiol Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents*/therapeutic use , Coinfection*/drug therapy , Coinfection*/virology , Hepacivirus*/drug effects , Hepacivirus*/physiology , Hepatitis C, Chronic*/drug therapy , Hepatitis C, Chronic*/virology , HIV Infections*/drug therapy , HIV Infections*/virology , Protease Inhibitors*/therapeutic use, Humans ; HIV-1/drug effects ; HIV-1/physiology ; Italy ; Medication Reconciliation ; Treatment Outcome

المؤلفون: Viganò A; Department of Paediatrics, L Sacco Hospital, University of Milan, Italy. alessandra.vigano@unimi.it, Brambilla P, Cafarelli L, Giacomet V, Borgonovo S, Zamproni I, Zuccotti G, Mora S

المصدر: Antiviral therapy [Antivir Ther] 2007; Vol. 12 (3), pp. 297-302.

نوع المنشور: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print Cited Medium: Print ISSN: 1359-6535 (Print) Linking ISSN: 13596535 NLM ISO Abbreviation: Antivir Ther Subsets: MEDLINE

مواضيع طبية MeSH: HIV-1*, Adenine/*analogs & derivatives , Anti-HIV Agents/*therapeutic use , Benzoxazines/*therapeutic use , HIV Protease Inhibitors/*therapeutic use , HIV-Associated Lipodystrophy Syndrome/*drug therapy , Organophosphonates/*therapeutic use , Protease Inhibitors/*therapeutic use , Stavudine/*therapeutic use, Absorptiometry, Photon ; Adenine/therapeutic use ; Adolescent ; Alkynes ; Antiretroviral Therapy, Highly Active ; Atrophy/pathology ; Body Composition/drug effects ; CD4 Lymphocyte Count ; Child ; Child, Preschool ; Cyclopropanes ; Female ; HIV Protease Inhibitors/adverse effects ; HIV-Associated Lipodystrophy Syndrome/diagnosis ; HIV-Associated Lipodystrophy Syndrome/etiology ; HIV-Associated Lipodystrophy Syndrome/immunology ; HIV-Associated Lipodystrophy Syndrome/virology ; Humans ; Italy ; Male ; Prospective Studies ; Protease Inhibitors/adverse effects ; Stavudine/adverse effects ; Tenofovir ; Time Factors ; Treatment Outcome ; Viral Load

عنوان ترانسليتريتد: La terapia dell'epatite cronica C: un problema (quasi) risolto.

المؤلفون: Rizzetto M

المصدر: Recenti progressi in medicina [Recenti Prog Med] 2014 Jun; Vol. 105 (6), pp. 225-6.

نوع المنشور: Editorial; English Abstract

بيانات الدورية: Publisher: Il Pensiero Scientifico Editore Country of Publication: Italy NLM ID: 0401271 Publication Model: Print Cited Medium: Print ISSN: 0034-1193 (Print) Linking ISSN: 00341193 NLM ISO Abbreviation: Recenti Prog Med Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents/*therapeutic use , Hepacivirus/*drug effects , Hepatitis C/*drug therapy , Protease Inhibitors/*therapeutic use, Antiviral Agents/economics ; Drug Therapy, Combination ; Hepatitis C/economics ; Hepatitis C, Chronic/drug therapy ; Humans ; Italy ; Protease Inhibitors/economics ; Treatment Outcome

المؤلفون: Stroppa EM; Oncology & Hematology Department, Oncology Unit, Piacenza General Hospital, Via Taverna 49, Piacenza, 29121, Italy., Toscani I; Oncology & Hematology Department, Oncology Unit, Piacenza General Hospital, Via Taverna 49, Piacenza, 29121, Italy., Citterio C; Oncology & Hematology Department, Oncology Unit, Piacenza General Hospital, Via Taverna 49, Piacenza, 29121, Italy., Anselmi E; Oncology & Hematology Department, Oncology Unit, Piacenza General Hospital, Via Taverna 49, Piacenza, 29121, Italy., Zaffignani E; Oncology & Hematology Department, Oncology Unit, Piacenza General Hospital, Via Taverna 49, Piacenza, 29121, Italy., Codeluppi M; Infectious Diseases Unit, Piacenza General Hospital, Via Taverna 49, Piacenza, 29121, Italy., Cavanna L; Oncology & Hematology Department, Oncology Unit, Piacenza General Hospital, Via Taverna 49, Piacenza, 29121, Italy.

المصدر: Future oncology (London, England) [Future Oncol] 2020 Jul; Vol. 16 (20), pp. 1425-1432. Date of Electronic Publication: 2020 May 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents/*therapeutic use , Coronavirus Infections/*drug therapy , Coronavirus Infections/*mortality , Hydroxychloroquine/*therapeutic use , Neoplasms/*mortality , Pneumonia, Viral/*drug therapy , Pneumonia, Viral/*mortality, Age Factors ; Aged ; Aged, 80 and over ; Azithromycin/therapeutic use ; Betacoronavirus ; COVID-19 ; Ceftriaxone/therapeutic use ; Cobicistat/therapeutic use ; Darunavir/therapeutic use ; Drug Therapy, Combination ; Female ; HIV Protease Inhibitors/therapeutic use ; Humans ; Italy ; Lopinavir/therapeutic use ; Male ; Methylprednisolone/therapeutic use ; Middle Aged ; Neoplasms/drug therapy ; Pandemics ; Ritonavir/therapeutic use ; SARS-CoV-2 ; COVID-19 Drug Treatment

المؤلفون: Antinori A; HIV/AIDS Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy., Cossu MV; 1st Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy., Menzaghi B; Infectious Diseases, Azienda Socio-Sanitaria Territoriale della Valle Olona-Busto Arsizio, Busto Arsizio, Italy., Sterrantino G; Division of Tropical and Infectious Disease, Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy., Squillace N; Clinic of Infectious Diseases, 'San Gerardo' Hospital, ASST Monza, Monza, Italy., Di Cristo V; DIBIC Luigi Sacco, Division of Infectious Diseases, University of Milan, Milan, Italy., Cattelan A; Division of Infectious and Tropical Diseases, Azienda Ospedaliero-Universitaria di Padova, Padua, Italy., Focà E; Department of Infectious and Tropical Diseases, University of Brescia and Spedali Civili General Hospital, Brescia, Italy., Castagna A; Department of Infectious Diseases, IRCSS San Raffaele Scientific Institute, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy., Orofino G; Unit of Infectious Diseases, Amedeo di Savoia Hospital, Turin, Italy., Valenti D; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy., D'Ettore G; Department of Public Health and Infectious Disease, Sapienza University, Rome, Italy., Aprea L; VIII Divisione di Malattie Infettive, A.O.R.N. Cotugno, Naples, Italy., Ferrara S; Department of Clinical and Experimental Medicine, Infectious Diseases Unit, University of Foggia, Foggia, Italy., Locatelli ME; UOC Malattie Infettive, ARNAS 'Garibaldi', Catania, Italy., Madeddu G; Unit of Infectious Diseases, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy., Pontali E; Infectious Diseases, E.O. Ospedali Galliera, Genoa, Italy., Scerbo P; Unit of Infectious Diseases, 'Pugliese-Ciaccio' Hospital, Catanzaro, Italy., Rossetti B; Infectious Diseases Unit, Siena University Hospital, Siena, Italy., Uglietti A; Medical Affairs Department, Infectious Diseases, Janssen-Cilag SpA, Via Michelangelo Buonarroti, 23, Cologno Monzese, 20093, Milan, Italy., Termini R; Medical Affairs Department, Infectious Diseases, Janssen-Cilag SpA, Via Michelangelo Buonarroti, 23, Cologno Monzese, 20093, Milan, Italy., Rucci F; Department of Oncology and Onco-Hematology, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milan, Milan, Italy., Gori A; Infectious Diseases Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.; Department of Infectious Diseases, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy., Mancusi D; Medical Affairs Department, Infectious Diseases, Janssen-Cilag SpA, Via Michelangelo Buonarroti, 23, Cologno Monzese, 20093, Milan, Italy. dmancusi@its.jnj.com.

المصدر: The patient [Patient] 2020 Jun; Vol. 13 (3), pp. 375-387.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101309314 Publication Model: Print Cited Medium: Internet ISSN: 1178-1661 (Electronic) Linking ISSN: 11781653 NLM ISO Abbreviation: Patient Subsets: MEDLINE

مواضيع طبية MeSH: Drug Therapy, Combination* , Patient Reported Outcome Measures*, Anti-HIV Agents/*administration & dosage , Cobicistat/*administration & dosage , Darunavir/*administration & dosage , HIV Infections/*drug therapy , HIV Protease Inhibitors/*administration & dosage, Adult ; Cohort Studies ; Female ; Humans ; Italy ; Male ; Middle Aged ; Patient Satisfaction ; Prospective Studies ; Surveys and Questionnaires